Segment Information (Tables)

12 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Schedule of Segment Perfomance Measures

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2013
Net sales	$	129,667	$	184,852	$	185,171	$	-		$	499,690
Gross profit		39,306		31,367		27,598		-			98,271
Income before income taxes		17,276		13,294		10,400		(6,420	)		34,550
2012
Net sales	$	105,249	$	162,998	$	176,141	$	-		$	444,388
Gross profit		29,932		25,472		26,628		-			82,032
Income before income taxes		11,683		8,066		10,570		(5,579	)		24,740
2011
Net sales	$	69,856	$	149,340	$	193,232	$	-		$	412,428
Gross profit		15,534		23,897		26,407		-			65,838
Income before income taxes		2,898		7,294		10,198		(3,428	)		16,962

Schedule of Net Sales and Gross Profit by Source Country

Net sales and gross profit by source country for the years ended June 30, 2013, 2012 and 2011 were as follows:

	Net Sales						Gross Profit
	2013		2012		2011		2013		2012		2011
United States	$	326,247	$	289,630	$	260,686	$	68,964	$	58,733	$	42,472
Germany		92,053		82,600		78,044		19,688		14,303		14,353
Netherlands		14,513		13,738		15,451		1,693		1,706		1,712
France		38,475		33,143		32,718		4,608		3,885		3,560
Asia-Pacific		28,402		25,277		25,529		3,318		3,405		3,741
Total	$	499,690	$	444,388	$	412,428	$	98,271	$	82,032	$	65,838

Schedule of Long-Lived Assets by Geographic Region

Long-lived assets by geographic region as of June 30, 2013 and June 30, 2012 were as follows:

	Long-lived assets
	2013		2012
United States	$	80,870	$	85,650
Europe		2,684		2,388
Asia-Pacific		2,213		2,413
Total	$	85,767	$	90,451